Study finds link between cannabinoid receptors, PTSD

05/14/2013 | MedicalDaily.com

A study using PET imaging found patients with PTSD had more cannabinoid type 1 receptors in brain areas associated with anxiety and fear compared with those who did not have the condition. The study, published in Molecular Psychiatry, also found that patients with PTSD had lower levels of the neurotransmitter anandamide, which causes greater numbers of CB1 receptors. The findings may help improve diagnosis and treatment of people with the condition.

View Full Article in:

MedicalDaily.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC